Ginseng and Diabetes: The Evidences from In Vitro, Animal and Human Studies

Panax ginseng exhibits pleiotropic beneficial effects on cardiovascular system, central nervous system, and immune system. In the last decade, numerous preclinical findings suggest ginseng as a promising therapeutic agent for diabetes prevention and treatment. The mechanism of ginseng and its active components is complex and is demonstrated to either modulate insulin production/secretion, glucose metabolism and uptake, or inflammatory pathway in both insulin-dependent and insulin-independent manners. However, human studies are remained obscure because of contradictory results. While more studies are warranted to further understand these contradictions, ginseng holds promise as a therapeutic agent for diabetes prevention and treatment. This review summarizes the evidences for the therapeutic potential of ginseng and ginsenosides from in vitro studies, animal studies and human clinical trials with a focus on diverse molecular targets including an AMP-activated protein kinase signaling pathway.

[1]  D. Kwon,et al.  Ginsenosides Rb1 and Rg1 Suppress Triglyceride Accumulation in 3T3-L1 Adipocytes and Enhance β-Cell Insulin Secretion and Viability in Min6 Cells via PKA-Dependent Pathways , 2008, Bioscience, biotechnology, and biochemistry.

[2]  L. Luo,et al.  American Ginseng Stimulates Insulin Production and Prevents Apoptosis through Regulation of Uncoupling Protein-2 in Cultured β Cells , 2006, Evidence-based complementary and alternative medicine : eCAM.

[3]  S. Woods,et al.  Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in Rats , 2010, Diabetes.

[4]  Kexin Li,et al.  Simultaneous determination of ginsenoside (G-Re, G-Rg1, G-Rg2, G-F1, G-Rh1) and protopanaxatriol in human plasma and urine by LC-MS/MS and its application in a pharmacokinetics study of G-Re in volunteers. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  G. Bell,et al.  Anti-diabetic effect of ginsenoside Re in ob/ob mice. , 2005, Biochimica et biophysica acta.

[6]  E. Kraegen,et al.  Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. , 2004, Biochemical and biophysical research communications.

[7]  Y. Oshima,et al.  Isolation and hypoglycemic activity of panaxans I, J, K and L, glycans of Panax ginseng roots. , 1985, Journal of ethnopharmacology.

[8]  Y. Oshima,et al.  Isolation and hypoglycemic activity of quinquefolans A, B, and C, glycans of Panax quinquefolium roots. , 1987, Journal of natural products.

[9]  Lawrence A Leiter,et al.  American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. , 2001, The American journal of clinical nutrition.

[10]  H. Aung,et al.  American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. , 2007, Journal of food science.

[11]  H. Ni,et al.  The study of ginsenoside on PPARγ expression of mononuclear macrophage in type 2 diabetes , 2010, Molecular Biology Reports.

[12]  H. Kim,et al.  Korean red ginseng stimulates insulin release from isolated rat pancreatic islets. , 2008, Journal of ethnopharmacology.

[13]  K. Amin,et al.  Effects of panax quinquefolium on streptozotocin-induced diabetic rats: role of C-peptide, nitric oxide and oxidative stress. , 2011, International journal of clinical and experimental medicine.

[14]  G. Ning,et al.  Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB. , 2008, Molecular endocrinology.

[15]  B. Wierusz-Wysocka,et al.  Type 2 diabetes mellitus as inflammatory disease , 2006 .

[16]  K. Park,et al.  The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes. , 2009, Biochemical and biophysical research communications.

[17]  S. Ko,et al.  Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice. , 2007, Journal of agricultural and food chemistry.

[18]  S. Chung,et al.  Ginseng Leaf Extract Prevents High Fat Diet-Induced Hyperglycemia and Hyperlipidemia through AMPK Activation , 2010 .

[19]  V. Vuksan,et al.  American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. , 2000, Archives of internal medicine.

[20]  Dong Il Kim,et al.  Effect of protopanaxadiol derivatives in high glucose-induced fibronectin expression in primary cultured rat mesangial cells: Role of mitogen-activated protein kinases and Akt , 2010, Archives of pharmacal research.

[21]  E. Ernst.  The RiskBenefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava , 2002, Annals of Internal Medicine.

[22]  Lawrence A Leiter,et al.  Null and Opposing Effects of Asian Ginseng (Panax ginseng C.A. Meyer) on Acute Glycemia: Results of Two Acute Dose Escalation Studies , 2003, Journal of the American College of Nutrition.

[23]  Zhengzhong Wang,et al.  The effects and mechanism of saponins of Panax notoginseng on glucose metabolism in 3T3-L1 cells. , 2009, The American journal of Chinese medicine.

[24]  D. Lai,et al.  Mediation of β-Endorphin by Ginsenoside Rh2 to Lower Plasma Glucose in Streptozotocin-Induced Diabetic Rats , 2006 .

[25]  Do Yeon Kim,et al.  Ginsenoside 20(R)-Rg3 stimulates glucose uptake in C2C12 myotubes via CaMKK-AMPK pathways , 2010 .

[26]  M. Birnbaum,et al.  Role of AMP-activated Protein Kinase in Cyclic AMP-dependent Lipolysis In 3T3-L1 Adipocytes* , 2003, Journal of Biological Chemistry.

[27]  R. E. Warren.  The stepwise approach to the management of type 2 diabetes. , 2004, Diabetes research and clinical practice.

[28]  Jae-Kwan Hwang,et al.  Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes. , 2006, Biological & pharmaceutical bulletin.

[29]  K. Kang,et al.  Comparison of the effects of Korean ginseng and heat-processed Korean ginseng on diabetic oxidative stress. , 2008, The American journal of Chinese medicine.

[30]  D. Kennedy,et al.  Panax ginseng has no effect on indices of glucose regulation following acute or chronic ingestion in healthy volunteers , 2008, British Journal of Nutrition.

[31]  Jin-Taek Hwang,et al.  Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. , 2010, Journal of ethnopharmacology.

[32]  K. Petersen,et al.  Mitochondrial dysfunction and type 2 diabetes , 2005, Current diabetes reports.

[33]  L. Critchley,et al.  Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo‐controlled human intervention trial , 2008, Diabetes, obesity & metabolism.

[34]  Seul-Gi Kim,et al.  The antidiabetic effect of ginsenoside Rb2 via activation of AMPK , 2011, Archives of pharmacal research.

[35]  T. Ikejima,et al.  Hypoglycemic mechanism of ginseng glycopeptide. , 2003, Acta pharmacologica Sinica.

[36]  C. Yuan,et al.  Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. , 2002, The American journal of Chinese medicine.

[37]  W. Banz,et al.  Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[38]  K. Sugiyama,et al.  Isolation and hypoglycaemic activity of panaxans A, B, C, D and E, glycans of Panax ginseng roots. , 1984, Planta medica.

[39]  Ki Sung Kang,et al.  Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats. , 2010, Biological & pharmaceutical bulletin.

[40]  Kee Chang Huang,et al.  The Pharmacology of Chinese Herbs , 1998 .

[41]  E. Kang,et al.  Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. , 2009, Metabolism: clinical and experimental.

[42]  Do Yeon Kim,et al.  Anti-Diabetic Effect of Pectinase-Processed Ginseng Radix (GINST) in High Fat Diet-Fed ICR Mice , 2011, Journal of ginseng research.

[43]  D. Kim.  Prevalence of diabetes and prediabetes among Koreans : the cohort data , 2011 .

[44]  L. Jia,et al.  Current evaluation of the millennium phytomedicine--ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations. , 2009, Current medicinal chemistry.

[45]  S. Chung,et al.  Anti-diabetic Effect and Mechanism of Korean Red Ginseng in C57BL/KsJ db/db Mice , 2008 .

[46]  Y. Rotshteyn,et al.  Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity. , 2004, Journal of ethnopharmacology.

[47]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[48]  D. Lai,et al.  Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. , 2006, Planta medica.

[49]  S. Chung,et al.  Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice , 2001, Archives of pharmacal research.

[50]  T. Yip,et al.  Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS. , 2006, Journal of ethnopharmacology.

[51]  Lawrence A Leiter,et al.  Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. , 2000, Diabetes care.

[52]  A. Rautio,et al.  Ginseng Therapy in Non-Insulin-Dependent Diabetic Patients: Effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight , 1995, Diabetes Care.

[53]  Hang-Ching Lin,et al.  Effect of ginsenosides on glucose uptake in human Caco-2 cells is mediated through altered Na+/glucose cotransporter 1 expression. , 2007, Journal of agricultural and food chemistry.

[54]  Kyong-Heon Kim,et al.  Ginsenoside Rg3 Suppresses Palmitate-Induced Apoptosis in MIN6N8 Pancreatic β-Cells , 2009, Journal of clinical biochemistry and nutrition.

[55]  Y. Oshima,et al.  Isolation and hypoglycemic activity of panaxans Q, R, S, T and U, glycans of Panax ginseng roots. , 1985, Journal of ethnopharmacology.

[56]  C. Yuan,et al.  American ginseng leaf: ginsenoside analysis and hypoglycemic activity. , 2004, Pharmacological research.

[57]  Mengwei Zang,et al.  AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. , 2011, Cell metabolism.

[58]  Jae-Kwan Hwang,et al.  Ginsenoside 20(S)-Protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes , 2006 .

[59]  Do Yeon Kim,et al.  Fermented Ginseng Attenuates Hepatic Lipid Accumulation and Hyperglycemia through AMPK Activation , 2009 .

[60]  Mi-Kyung Sung,et al.  Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-α, PPAR-γ, and LPL mRNA expressions , 2005 .

[61]  K. Polonsky,et al.  Ginseng and Ginsenoside Re Do Not Improve β-Cell Function or Insulin Sensitivity in Overweight and Obese Subjects With Impaired Glucose Tolerance or Diabetes , 2011, Diabetes Care.

[62]  D. Zheng,et al.  Muscle Glucose Transporter (GLUT 4) Gene Expression during Exercise , 2000, Exercise and sport sciences reviews.

[63]  S. Ko,et al.  Vinegar- processed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice , 2007, Archives of pharmacal research.

[64]  Do Yeon Kim,et al.  Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells. , 2012, Chemico-biological interactions.

[65]  K. Kang,et al.  Protective effect of heat-processed American ginseng against diabetic renal damage in rats. , 2007, Journal of agricultural and food chemistry.

[66]  S. Kao,et al.  INCREASE OF INSULIN SECRETION BY GINSENOSIDE RH2 TO LOWER PLASMA GLUCOSE IN WISTAR RATS , 2006, Clinical and experimental pharmacology & physiology.

[67]  Juan Qin,et al.  Effects of Panax notoginoside on the expression of TGF-β1 and Smad-7 in renal tissues of diabetic rats , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[68]  K. Kang,et al.  Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats. , 2008, European journal of pharmacology.

[69]  S. Chung,et al.  Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells. , 2010, Biological & pharmaceutical bulletin.

[70]  S. Koo,et al.  AMPK-dependent Repression of Hepatic Gluconeogenesis via Disruption of CREB·CRTC2 Complex by Orphan Nuclear Receptor Small Heterodimer Partner* , 2010, The Journal of Biological Chemistry.

[71]  T. Kaptchuk,et al.  Systematic review of herbs and dietary supplements for glycemic control in diabetes. , 2003, Diabetes care.

[72]  Lawrence A Leiter,et al.  Konjac-Mannan and American Ginsing: Emerging Alternative Therapies for Type 2 Diabetes Mellitus , 2001, Journal of the American College of Nutrition.

[73]  Young Guk Park,et al.  Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice. , 2011, International journal of molecular medicine.

[74]  Lawrence A Leiter,et al.  Decreasing, Null and Increasing Effects of Eight Popular Types of Ginseng on Acute Postprandial Glycemic Indices in Healthy Humans: The Role of Ginsenosides , 2004, Journal of the American College of Nutrition.

[75]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[76]  Lawrence A Leiter,et al.  Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[77]  S. Chung,et al.  Protective effects of fermented ginseng on streptozotocin-induced pancreatic beta-cell damage through inhibition of NF-kappaB. , 2009, International journal of molecular medicine.

[78]  Li-juan Wang,et al.  Hypoglycemic effects of malonyl‐ginsenosides extracted from roots of Panax ginseng on streptozotocin‐induced diabetic mice , 2009, Phytotherapy research : PTR.

[79]  S. Chung,et al.  Fermented ginseng protects streptozotocin‐induced damage in rat pancreas by inhibiting nuclear factor‐κB , 2010, Phytotherapy research : PTR.

[80]  Qingnian Tu 屠庆年,et al.  Effects of Panax notoginoside on the expression of TGF-β1 and Smad-7 in renal tissues of diabetic rats , 2011, Journal of Huazhong University of Science and Technology [Medical Sciences].

[81]  D. Basila,et al.  Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng , 2005, Acta Pharmacologica Sinica.

[82]  Duane D. Miller,et al.  Recent and emerging anti‐diabetes targets , 2009, Medicinal research reviews.

[83]  S. Haffner.  Pre-diabetes, insulin resistance, inflammation and CVD risk. , 2003, Diabetes research and clinical practice.

[84]  Yuan Zhao,et al.  Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components. , 2010, Journal of ethnopharmacology.

[85]  O. Lee,et al.  Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3‐L1 adipocytes , 2011, Phytotherapy research : PTR.

[86]  Libin Zhou,et al.  Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. , 2008, The Journal of endocrinology.

[87]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[88]  L. G. Miller,et al.  Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. , 1998, Archives of internal medicine.

[89]  W. Cho,et al.  Application of proteomics in Chinese medicine research. , 2007, The American journal of Chinese medicine.

[90]  K. Kang,et al.  Protective effect of sun ginseng against diabetic renal damage. , 2006, Biological & pharmaceutical bulletin.

[91]  A. McCullough.  Epidemiology of the metabolic syndrome in the USA , 2011, Journal of digestive diseases.

[92]  V. Vuksan,et al.  Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[93]  C. Yuan,et al.  Ginseng and diabetes. , 2005, The American journal of Chinese medicine.

[94]  Norman Fleischer,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. , 1993 .

[95]  K. Polonsky,et al.  Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. , 2002, Diabetes.

[96]  S. Chung,et al.  Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice. , 2007, Biological & pharmaceutical bulletin.

[97]  S. Chung,et al.  Beneficial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate-activated protein kinase and phosphatidylinositol-3 kinase pathways. , 2011, Metabolism: clinical and experimental.

[98]  J. Bland,et al.  Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice. , 2010, Journal of medicinal food.